Area of research
Pulmonary and Respiratory Medicine · Oncology
Research interest
Research focused on Cancer research and Immunotherapy, with related work in Lung cancer, Nomogram, Pyroptosis. Notable publications include 'Photodynamic therapy induces human esophageal carcinoma cell pyroptosis by targeting the PKM2/caspase-8/caspase-3/GSDME axis', 'UBE2T promotes autophagy via the p53/AMPK/mTOR signaling pathway in lung adenocarcinoma', and 'Analysis of multiple programmed cell death-related prognostic genes and functional validations of necroptosis-associated genes in oesophageal squamous cell carcinoma'.
Integrating bulk, single-cell, and spatial transcriptomics to identify and functionally validate novel targets to enhance immunotherapy in NSCLC
RFX2-BNIP3 axis-driven adaptive mitophagy promotes resistance to ACK1-targeted therapy in non-small cell lung cancer
METTL3-mediated deficiency of lncRNA HAR1A drives non-small cell lung cancer growth and metastasis by promoting ANXA2 stabilization
LncRNA HAR1A inhibits non-small cell lung cancer growth by downregulating c-MYC transcripts and facilitating its proteasomal degradation
An immune-related gene pair signature predicts the prognosis and immunotherapeutic response in glioblastoma
Analysis of multiple programmed cell death-related prognostic genes and functional validations of necroptosis-associated genes in oesophageal squamous cell carcinoma
<i>LINC00669</i> promotes lung adenocarcinoma growth by stimulating the Wnt/β‐catenin signaling pathway
Integrating DOI in T classification improves the predictive performance of laryngeal cancer staging
Improvement of ACK1-targeted therapy efficacy in lung adenocarcinoma using chloroquine or bafilomycin A1
LncRNA HAR1A Suppresses the Development of Non-Small Cell Lung Cancer by Inactivating the STAT3 Pathway
Pan-cancer analysis of UBE2T with a focus on prognostic and immunological roles in lung adenocarcinoma
Prognostic and Immunological Implications of FAM72A in Pan-Cancer and Functional Validations
Photodynamic therapy induces human esophageal carcinoma cell pyroptosis by targeting the PKM2/caspase-8/caspase-3/GSDME axis
UBE2T promotes autophagy via the p53/AMPK/mTOR signaling pathway in lung adenocarcinoma
Identification of downstream signaling cascades of ACK1 and prognostic classifiers in non-small cell lung cancer
Prediction of prognosis and immunotherapy response with a robust immune-related lncRNA pair signature in lung adenocarcinoma
Development of immune gene pair-based signature predictive of prognosis and immunotherapy in esophageal cancer
Assessment of immune status of laryngeal squamous cell carcinoma can predict prognosis and guide treatment
UBE2T Contributes to the Prognosis of Esophageal Squamous Cell Carcinoma
Identification of Immune-Related LncRNA Pairs for Predicting Prognosis and Immunotherapeutic Response in Head and Neck Squamous Cell Carcinoma
Corrigendum to “Photodynamic therapy induces human esophageal carcinoma cell pyroptosis by targeting the PKM2/caspase-8/caspase-3/GSDME axis” [Cancer Lett. 520 (2021) 143–159]